Neo

MD/Drug Developer. Disclaimer: Not financial advice.

[Neo @NEObioMATRIX]

@ProfTomEllis Bubbly bubbly

[Neo @NEObioMATRIX]

@hassankhan Gtfo brotha

[Neo @NEObioMATRIX]

@karine_hsu Don’t worry. It’s all good Karine

[Neo @NEObioMATRIX]

@justindubinmd Based

[Neo @NEObioMATRIX]

@MidwestHedgie Just move to a house already with your own private gym to avoid the clowns

[Neo @NEObioMATRIX]

@JoshuaKushner Like optimize taxes for the expected exit strategy, Josh?

[Neo @NEObioMATRIX]

@fulop_dan They have to mate. When you underwrite $100M series A with no revenues for the next decade, you have to be risk averse on the scientific side. Otherwise you’ll go bust. It is what it is

[Neo @NEObioMATRIX]

@AppleHelix He is delusional

[Neo @NEObioMATRIX]

@RayneWothbaum @ky_lahucik Imbeciles… who is the idiot investing in them?

[Neo @NEObioMATRIX]

@biotech_bro Most correct. Documents enthusiastic yes, recruitment hard no, protocol is the same as document creation.

[Neo @NEObioMATRIX]

@JoshuaSteinman No. Unless you want dangerous placebo to be administered to your sick child

[Neo @NEObioMATRIX]

@dhh Fuck
You
That’s awesome

[Neo @NEObioMATRIX]

@matt_is_nice That’s all good but we can be doing, or at least considering, in all Ph2 trials

[Neo @NEObioMATRIX]

@matt_is_nice You can maybe reduce sample size a little with digital twins if you want to take that risk…

[Neo @NEObioMATRIX]

@KarenLorre Imbecile. Focus on acting instead if you believe this

[Neo @NEObioMATRIX]

@daphnezohar It worked in the end

[Neo @NEObioMATRIX]

@mcuban @DrDiGiorgio You cannot pay us enough Mark. It’s fine. We do it anyways

[Mark Cuban @mcuban]

@DrDiGiorgio All doctors are underpaid.